40
Participants
Start Date
September 30, 2012
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Dasatinib + PegIFN
Helsinki University Central Hospital, Helsinki
Bergen University Central Hospital, Bergen
Rikshospitalet, Oslo
Stavanger University Hospital, Stavanger
University Hospital of Northern Norway, Tromsø
St Olavs Hospital - Trondheim University Hospital, Trondheim
Linköping University Hospital, Linköping
Sunderby Sjukhus, Luleå
Lund University Hospital, Lund
Örebro University Hospital, Örebro
Karolinska University Hospital, Stockholm
Sundsvall County Hospital, Sundsvall
Umeå University Hospital, Umeå
Uppsala University Hospital, Uppsala
Norwegian University of Science and Technology
OTHER